CD8+ T Cells as a Source of IFN-γ Production in Human Cutaneous Leishmaniasis by Nateghi Rostami, Mahmoud et al.
CD8
+ T Cells as a Source of IFN-c Production in Human
Cutaneous Leishmaniasis
Mahmoud Nateghi Rostami
1,2, Hossein Keshavarz
1, Rosita Edalat
3, Abdolfattah Sarrafnejad
4, Tahereh
Shahrestani
4, Fereidoun Mahboudi
4, Ali Khamesipour
5*
1Medical Parasitology and Mycology Department, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran, 2Faculty of Health, Qom University of
Medical Sciences, Qom, Iran, 3Biotechnology Department, Pasteur Institute of Iran, Tehran, Iran, 4Immunology Department, School of Public Health, Tehran University of
Medical Sciences, Tehran, Iran, 5Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran
Abstract
Background: In human leishmaniasis Th1/Th2 dichotomy similar to murine model is not clearly defined and surrogate
marker(s) of protection is not yet known. In this study, Th1/Th2 cytokines (IL-5, IL-10, IL-13 and IFN-c) profile induced by
purified CD4
+/CD8
+ T cells in response to Leishmania antigens were assessed at transcript and protein levels in 14
volunteers with a history of self-healing cutaneous leishmaniasis (HCL) and compared with 18 healthy control volunteers.
Methodology/Principal Findings: CD4
+/CD8
+/CD14
+ cells were purified from peripheral blood using magnetic beads;
CD4
+/CD8
+ T cells were co-cultured with autologous CD14
+ monocytes in the presence of soluble Leishmania antigens
(SLA). Stimulation of either CD4
+ T cells or CD8
+ T cells of HCL volunteers with SLA induced a significantly (P,0.05) higher
IFN-c production compared with the cells of controls. Upregulation of IFN-c gene expression in CD4
+ cells (P,0.001) and
CD8
+ cells (P=0.006) of HCL volunteers was significantly more than that of controls. Significantly (P,0.05) higher fold-
expression of IFN-c gene was seen in CD4
+ cells than in CD8
+ cells. In HCL volunteers a significantly (P=0.014) higher
number of CD4
+ cells were positive for intracellular IFN-c production than CD8
+ cells.
Conclusions/Significance: Collectively, the volunteers have shown maintenance of specific long-term immune responses
characterized by a strong reaction to leishmanin skin test and IFN-c production. The dominant IFN-c response was the result
of expansion of both CD4
+ and CD8
+ T cells. The results suggested that immune response in protected individuals with a
history of zoonotic cutaneous leishmaniasis (ZCL) due to L. major is mediated not only through the expansion of antigen-
specific IFN-c producing CD4
+ Th1 cells, but also through IFN-c producing CD8
+ T cells.
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Introduction
Leishmaniasis is expanding both by increasing the incidence rate
in endemic foci and extending the disease to new regions [1,2].
Control measures against leishmaniasis are not fully effective,
chemotherapy is not always successful, and drug resistant is
emerging [3–5]. Although theoretically development of an effective
vaccine against leishmaniasis is feasible but yet there is no vaccine
available against any form of leishmaniasis [6,7]. CD4
+ T cells upon
activation differentiate into functional effector Th1 and/or Th2
subsets and the outcome of Leishmania major infection in murine
modelisdependentupon the type ofimmuneresponsegenerated:in
moststrainsofmiceL.majorinfectioninducesaTh1typeofresponse
associated with a high level of IFN-c, low level of IL-4, and similar
to human cutaneous leishmaniasis the lesion(s) heals spontaneously
and the animals are protected against further infection; whereas L.
major infection in BALB/c mice induces a Th2 response and a high
level of IL-4 and low level of IFN-c, as a result the disease is fetal
[8,9]. The mechanism(s) of protection in human leishmaniasis is not
well characterized; however, the role of T lymphocytes and Th1/
Th2 cytokine profile are extensively studied [10–16]. In human
leishmaniasis, peripheral blood mononuclear cells (PBMC) are
routinely collected from patients with different clinical pictures of
cutaneous leishmaniasis (CL) for immunological investigations.
Results from the majority of these studies showed that PBMC of
healing orcured casesofCL producesignificant amountof IFN-c in
response to Leishmania antigens [17,18]. There is evidence
demonstrating CD4
+ T cells collected from patients with CL or
mucocutaneousleishmaniasis(ML) orindividualswithhistoryofCL
produced a high level of IFN-c in response to Leishmania antigens
which is an indication of a Th1 like response [10,11]; Conversely, T
cells from patients with diffuse CL (DCL) failed to express IL-2
receptor and did not produce IFN-c in response to Leishmania
antigens, whereas IL-4 mRNA markedly increased in DCL lesions
[17,18]. A clearTh1/Th2 dichotomysimilartomurine modelisnot
yet defined in human leishmaniasis [19].
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+ T cells play a role in
controlling intracellular pathogens including protozoal and viral
infections. CD8
+ T cells are shown to confer a significant role in
protection against acute and chronic form of Toxoplasma gondii
infection [20]. In early stage of murine toxoplasmosis, CD8
+ T
cells hamper parasite dissemination by either direct lysis of
infected cells or through release of cytokines. During chronic
infection CD8
+ T cells limit Toxoplasma cyst formation in tissues
[21,22]. Immunity against malarial sporozoites is mediated
partially by neutralizing antibodies, but largely depends on
antigen specific CD8
+ T cells, thus vaccines are designed based
on induction of infection-blocking CD8
+ T cells [23,24]. CD8
+ T
cells are also important in the control of HIV infection [25–27].
During HIV infection, CD8
+ T cells recognize infected cells
through an MHC-I dependent process and viral infected cells are
lysed by secretion of perforin and granzymes [28]. Most patients
chronically infected with HIV show CD8
+ T cell response against
HIV virus, but the response is not enough to successfully control
viral replication [25–27]. In Listeria monocytogenes infection, both
CD4
+ and CD8
+ T cells contribute in induction of protection, but
the major bactericidal role is attributed to CD8
+ T cells [29]. In
experimental models of leishmaniasis, CD8
+ T cells, in cooper-
ation with CD4
+ T cells, appear to be involved in the induction of
host immunity against both primary infection and reinfection of
Leishmania parasite [30–32]. In L. major infected CD8
+ depleted
BALB/c mice, during lesion healing the frequency of IFN-c
producing CD4
+ T cells and the amount of IFN-c are diminished
resulted in a higher parasite burden [30]. In a study performed on
C57BL/6 mice, infection with low dose of L. major induces a
transient Th2 type response and then shifts to a Th1 response
associated with healing. Induction of this Th1 type of response
partly depends on the activation of IFN-c producing CD8
+ T cells
and in the absence of CD8
+ T cells, the Th2 response is sustained
[33]. In mouse model of both genetically resistant and susceptible
(that were rendered resistant) backgrounds, CD8
+ T cells have
been demonstrated to produce IFN-c and contribute to the rapid
healing of secondary lesions which develop after primary challenge
with L. major [31].
There are reports from New World leishmaniasis which showed
that CD8
+ T cells are involved in healing process of CL due to L.
braziliensis [34–37]. However, to our knowledge there is no data
available about the possible role of CD8
+ T cells and their
cytokines in CL due to L. major.
In leishmaniasis, most of the data generated so far is drawn from
PBMCs culture without separation of T cell subtypes
[10,12,13]which makes it difficult to judge the role of Th1/Th2
CD4
+ cells and CD8
+ T cells. In the current study two major
lymphocyte subtypes, CD4
+ and CD8
+ T cells, were purified from
individuals with history of self-healing CL and cytokine pattern
were analyzed at transcript and protein levels in response to
Leishmania antigens.
Materials and Methods
Study population and ethical considerations
The study was approved by Ethical Committee of Tehran
University of Medical Sciences. Potential candidates were invited
and those who were willing to participate and sign a written
informed consent were recruited.
Fourteen volunteers with history of self-healing CL (HCL)
caused by L. major and with leishmanin skin test (LST) more than
zero and as control 18 healthy volunteers from non-endemic area
with no response to LST were included. HCL volunteers were
selected among the previous Center’s patient who received no
treatment for the CL lesion(s) and the lesion(s) cured spontaneously
within one year of onset. The causative agent of every CL patient
was previously identified as L. major using PCR method.
Soluble Leishmania antigen preparation
Leishmania major (MRHO/IR/75/ER) was cultured on NNN
medium and passaged on RPMI 1640 (Gibco Invitrogen,
Carlsbad, CA, USA) supplemented with 10% fetal calf serum
(FCS). Promastigotes were harvested at day 5, washed 3 times with
PBS (pH 7.2) and used for preparation of soluble Leishmania
antigen (SLA) as previously described [14]. Briefly, protease
inhibitor cocktail enzyme (Sigma, St. Louis, MO, USA) was added
at 100 ml per 1610
9 promastigotes, and then the parasites were
freeze-thawed 10 times followed by sonication at 4uC with two 20-
sec blasts. Parasite suspension was centrifuged at 30,0006g for
20 min, the supernatant was collected and re-centrifuged at
100,0006g for 4 hours. SLA protein concentration was measured
using Bradford method [38]. Finally the supernatant was sterilized
using 0.22 mm membrane filter, aliquoted and stored at 220uC
until use.
Purification of CD4
+/CD8
+/CD14
+ cells
Twenty mL of blood sample was collected from each volunteer
and Peripheral Blood Mononuclear Cells (PBMCs) were isolated
using Ficoll–Hypaque (Sigma, St. Louis, MO, USA) density
gradient centrifugation. CD4
+ and CD8
+ lymphocytes isolation
was performed using magnetic beads system (StemCell Technol-
ogies Inc., Vancouver, BC, Canada) by positive selection using
anti-CD4 or anti-CD8 coated nanoparticles. Briefly, cell suspen-
sion was prepared at a concentration of 1610
7 cells/ml in a 5 ml
tube in isolation buffer containing PBS plus 2% (v/v) FBS and
1 mM EDTA. EasySep CD4/CD8 cocktail Abs was added at
10 ml/ml cells, mixed well and incubated at room temperature
(RT) for 15 min. Magnetic nanoparticles were added at 5 ml/ml
cells and incubated for 10 min at RT. The cell suspension was
brought to 2.5 ml by adding buffer and the tube was placed into
the magnet for 5 min, then the supernatant was discarded. The
Author Summary
Cutaneous leishmaniasis (CL) is usually a self-healing skin
lesion caused by different species of Leishmania parasite.
Resistance and susceptibility of mice to Leishmania major
infection is associated with two types of CD4+ T
lymphocytes development: Th1 type response with
production of cytokine IFN-c is associated with resistance,
whereas Th2 type response with production of cytokines
IL-4 and IL-5 is associated with susceptibility. A clear Th1/
Th2 dichotomy similar to murine model is not defined in
human leishmaniasis and we need as much information as
possible to define marker(s) of protection. We purified
CD4
+/CD8
+ T cells, stimulated them with Leishmania
antigens and analysed gene and protein expression of
Th1/Th2 cytokines in volunteers with a history of self-
healing CL who are presumed to be protected against
further Leishmania infection. We have seen significant
upregulation of IFN-c gene expression and high IFN-c
production in the Leishmania stimulated CD4
+ T cells and
CD8
+ T cells. We concluded that both antigen-specific IFN-
c producing CD4
+ Th1 cells and IFN-c producing CD8
+ T
cells contribute to the long term protection in individuals
with a history of CL. This proves the importance of CD8+ T
cells as a source of IFN-c in Th1-like immune responses.
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placing tube into the magnet were repeated three times.
Monocytes (CD14
+) were isolated from autologous PBMC by
negative selection according to the manufacturer’s instruction
(StemCell Technologies Inc., Vancouver, BC, Canada). Briefly,
cell suspension was prepared at a concentration of 5610
6 cells/ml
in isolation buffer. EasySep monocyte enrichment cocktail Abs was
added at 5 ml/ml cells, mixed well and incubated at 4uC for
10 min. Magnetic microparticles were added at 5 ml/ml cells for
5 min at 4uC. The cell suspension was brought to 2.5 ml by
adding buffer and the tube was placed into the magnet, for
2.5 min at RT. The desired unbound fraction was transferred into
a new tube.
The purity of the yielded lymphocytes or monocytes was more
than 95% by flow cytometry analysis using specific conjugated
mAb (Fig. 1). The contamination of CD8
+ T cells with NK cells
was less than 9% using a-CD56 mAb.
Purified CD4
+/CD8
+ T cell culture
Monocytes were co-cultured with sorted lymphocytes as antigen
presenting cells (APCs) following mitomycin C (Merk, Darmstadt,
Germany) treatment at a final concentration of 10 mg/ml for
30 min at 37uC with 5% CO2.
The cells were cultured in RPMI 1640 media supplemented
with 10% heat-inactivated human AB Rh+ serum, 10 mM/L
Hepes, 2 mM L-glutamine, 100 U/ml penicillin G and 100 mg/
ml streptomycin (Gibco Invitrogen, Carlsbad, CA, USA). CD4
+ or
CD8
+ lymphocytes were adjusted to 0.5–1610
6 cells/ml mixed
with 1:10 of autologous monocytes and were cultured in U-
bottomed 96-well plates (Nunc, Roskilde, Denmark) in the
Figure 1. The purity of peripheral blood enriched CD4
+ and CD8
+ T cell populations after magnetic beads isolation. CD4
+ (A) and
CD8
+ (B) lymphocytes were isolated from a cell suspension of PBMC by positive selection using CD4/CD8 cocktail Abs and anti-CD4 or anti-CD8
coated magnetic nanoparticles. The purity of yielded T cell populations was analysed by flow cytometry using conjugated mAbs.
doi:10.1371/journal.pntd.0000845.g001
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volume of 200 ml. Plates were incubated at 37uC with 5% CO2 in
humidified atmosphere for 72 hrs.
ELISA cytokine assay
Culture supernatants were collected at 72 hours, the level of IL-
5, IL-10, IL-13 and IFN-c were titrated in culture supernatants
using ELISA method (Mabtech, Stockholm, Sweden). Briefly, the
plates were coated with anti-IFN-c/IL-5/IL-10/IL-13 mAb in
PBS, pH 7.4, and incubated at 4uC over night. After blocking the
wells using buffer containing PBS plus 0.05% (v/v) Tween 20 and
0.1% (w/v) BSA, supernatants were added to each well. Biotin-
labeled mAb in incubation buffer was added to each well and as
enzyme streptavidin-HRP was used. The reaction was developed
using 3,39,5,59-tetramethylbenzidine (TMB) substrate and stopped
with 0.5M H2SO4 solution. The plates were washed after each
step of incubation using PBS+0.05% (v/v) Tween20. The plates
were read at 450 nm using a reader (BioTek, Winooski, VT,
USA). The mean optical densities (ODs) of triplicate cultures were
compared with the standard curves prepared using recombinant
IL-5, IL-10, IL-13 and IFN-c. The cytokine levels represent the
differences between the ODs of test and background wells. The
detection limit of the assays was 4 pg/ml for IL-5 and 0.5 pg/ml
for IL-10, 5 pg/ml for IL-13 and 2 pg/ml for IFN-c.
Intracellular Cytokine Staining (ICS)
After SLA stimulation, part of the cells was used for ICS assay.
Cells were adjusted at 5610
5 per ml and stimulated with PMA
(Sigma, St. Louis, MO, USA) 50 ng/ml plus Ionomycin calcium
(Sigma) 500 ng/ml and incubated at 37uC, 5% CO2 for 5–6 hrs.
Monensin (Sigma) was added at 25 mM/ml during the last 4–5 hrs
of culture for blocking. Cells were harvested and washed 2 times
with PBS (pH 7.2) plus 0.1% bovine serum albumin (BSA). The
cells were permeabilized using BD Cytofix/Cytoperm kit according
to the manufacturer’s instruction (BD Biosciences, San Jose, CA,
USA). In the final step, cells were stained with FITC-conjugated
mouse anti-human IFN-c and PE-conjugated rat anti-human IL-2
(BD Biosciences, San Jose, CA, USA). Cells were washed 62 with
perm/wash buffer and resuspended in PBS (pH 7.2) plus 1% BSA.
Cells were analyzed using Partec flow cytometer (DAKO cytoma-
tion, Glostrup, Denmark) while isotype matched negative controls
were used to set the threshold of autofluorescence. A minimum of
50,000 events were acquired for each sample. FACS data analysis
was performed using FloMax (DAKO cytomation) software.
RNA extraction
At the time of supernatants collection (at day 3), the SLA
stimulated cells were harvested and used for RNA extraction. The
procedure began with reverse transcription of mRNA to cDNA.
The cDNA was then used as template for Real-time PCR using
specific primer of each cytokine. Solutions were treated and
glassware was filled with 0.1% (v/v) diethylpyrocarbonate (DEPC)
(Merck, Darmstadt, Germany) in H2O.
The cell pellet was resuspended in cold PBS (pH 7.2) and lysed
by addition of 0.2 mL of Trizol (Sigma, St. Louis, MO, USA) per
1610
6 cells. RNA was solublized through pipetting and incubated
at RT for 5 min. Then 0.2 ml chloroform was added per 1 ml of
homogenate, the suspension was shook vigorously and kept on ice
for 5 min followed by centrifugation for 15 min, 12,0006ga t4 uC.
The upper phase was collected and added to an equal volume of
isopropanol and incubated at 4uC over night. Then the cell
suspension was centrifuged at 12,0006g, 4uC for 15 min, the
supernatant was discarded and the RNA pellet was washed with
1 ml 75% ethanol at 7,5006g for 8 min. At the end, the pellet was
drayed briefly and dissolved in DEPC treated water. The purity of
RNA samples was assessed by the ratio of ODs at 260/280 nm
using UV spectrophotometry.
Real-time PCR
Reverse transcription was carried out using RevertAid M-
MuLV enzyme (Fermentas life sciences, York, UK) in a 30 mL
reaction mixture. Briefly, 1 mL (0.5 mg) of oligo dT18 primer was
added to about 3 mg of total RNA, mixed and incubated at 70uC
for 5–10 min. The tube was placed on ice for a few minutes,
centrifuged briefly and added with: 4 mLo f5 6 reaction buffer,
1 mL 10 mM dNTPs, 20 u RNase inhibitor (RiboLock; Fermentas
life sciences) and DEPC treated water up to 30 mL. Tube was
incubated at 37uC for 5 min, the contents were mixed gently and
then added with 100 U of enzyme. The reaction mixture was
incubated at 42uC for 60 min. The enzyme was inactivated by
heating at 70uC for 10 min. and chilled on ice. In a Real-time
PCR MicroAmp optical 96-well reaction plate (Applied Biosys-
tems, Foster City, CA, USA) for 25 ml reaction mixture the
followings in each optical well were prepared: 12.5 ml QuantiTect
SYBR Green I (Qiagen, Hilden, Germany), 3 ml cDNA, 2 ml
primer pair mix (0.5 mM each), 7.5 ml dH2O (For sequences of
primer pairs see Table 1).
For normalizing the difference in the amount of inputting
cDNAs, the housekeeping gene glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) was used as the internal standard.
Samples and internal standard were amplified in separate wells of
the plate. Two-step thermal profile as a PCR program was set up
on the SDS software (version 1.3.1) of Applied Biosystems 7,500
machine (Applied Biosystems, Foster City, CA, USA).
{950C 5 min 1 cycle
{950C1 5s w600C 32 s 40 cycles
Table 1. Sequence of primer pairs for different amplicons.
GENE FORWARD REVERSE PRODUCT SIZE (bp)
IFN-c IFN-TGTCCAACGCAAAGCAATAC TCGACCTCGAAACAGCATCT 106
IL-5 CTTGGCACTGCTTTCTACTCATC TGCAGGTAGTCTAGGAATTGGTT 261
IL-10 GCCGTGGAGCAGGTGAAG AGTCGCCACCCTGATGTCT 144
IL-13 AACATCACCCAGAACCAGAAG CAGAATCCGCTCAGCATCC 158
GAPDH GAAGGTGAAGGTCGGAGTC GAAGATGGTGATGGGATTTC 226
doi:10.1371/journal.pntd.0000845.t001
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follows:
{950C1 5s w600C 1 minw950C 15 s 1 cycle
Software generates reports including amplification plots and
dissociation curves. Any bimodal dissociation curve or abnormal
amplification plots were checked to see if there is an indication of
different Tms and nonspecific products.
The Ct (threshold cycle) of each sample was used in gene
relative expression calculation. The 2
2DDCt method was used to
calculate relative changes in the gene expressions:
Normalized relative expression of sample to calibrator~2{DDCt
While
DCt~Ct Target{Ct GAPDH; and
DDCt~DCt treated sample{DCt unstimulated blank:
Efficiency assay: Validation of DDCT method
To have a valid calculation of 2
2DDCt, the amplification
efficiencies of the target and reference (GAPDH) genes must be
approximately equal. For this purpose, the Ct values variation
with cDNA template dilutions was checked. A pooled cDNA
preparation was diluted over a 10-fold range and PCR was
performed for each dilution using specific primers. A plot of the
log cDNA dilution versus CT was prepared. The slope of each line
was obtained from regression equation and the efficiencies of the
target and reference genes were calculated using the equation:
Efficiency (E)=[10
(1/slop)]21
Statistical analysis
Non-parametric tests of Mann-Whitney, Kruskal-Wallis and
Dunn’s post-test for paired comparisons were used for statistical
analysis of the data using SPSS version 11.5 (SPSS Inc., Chicago,
IL, USA) and GraphPad Prism version 5.01 (GraphPad Software
Inc., La Jolla, CA, USA) softwares. Nonparametric tests were
chosen because the samples did not follow a Gaussian distribution.
P value of ,0.05 considered to be significant.
Results
Basic information of the studied population is outlined in
Table 2.
ELISA for cytokine production assay for CD4
+/CD8
+ T cells
Using ELISA method, cytokine profile (IFN-c, IL-10, IL-13)
were measured on supernatants collected at 72 hrs of SLA
stimulated PBMC or CD4
+, CD8
+ T cells culture. The amount of
IFN-c level was significantly higher in PBMC culture of HCL
volunteers compared with that of healthy controls (P,0.05).
Results of purified T cell culture showed that stimulated CD4
+ T
cells from HCL volunteers induced a significantly higher IFN-c
production compared with cells from healthy controls (P,0.05)
(Fig. 2A). Similarly, stimulated CD8
+ T cells from HCL volunteers
induced a significantly higher IFN-c production compared with
the cells from healthy controls (P,0.05) (Fig. 2B). The levels of IL-
10 and IL-13 were not significantly different in either CD4
+ or
CD8
+ T cells between HCL volunteers and healthy controls
(Fig. 2A and B). IL-5 level was not detectable in culture
supernatants of either CD4
+ or CD8
+ T cells.
Real-time PCR for cytokine mRNA expression assay in
CD4
+/CD8
+ T cells
The relative quantities of the target genes were normalized
against the relative quantities of the internal standard (GAPDH).
Ct values of amplified templates of antigenic stimulated T cells
were used for calculation of different cytokine gene expressions
using 2
2DDCT method. The expression amount was compared
with unstimulated cells of culture and relative fold-expression was
reported. Result for each donor was calculated and then data was
pooled and presented as a mean of HCL volunteers against
healthy controls. Results showed that the upregulation of IFN-c
gene expression in CD4
+ cells from HCL volunteers was
significantly higher than that of healthy controls (P,0.001)
(Fig. 3A). Similarly, fold-expression changes of IFN-c gene was
significantly higher in CD8
+ cells from HCL volunteers compared
to the cells from healthy controls (P=0.006) (Fig. 3B). Comparing
CD4
+ and CD8
+ T cells, the significantly higher fold-expression of
IFN-c gene was seen in CD4
+ cells than CD8
+ cells of HCL
volunteers.
In both CD4
+ and CD8
+ T cell cultures, the changes in the gene
expression of IL-5, IL-10 and IL-13 were not significantly different
between HCL volunteers and healthy controls.
By amplification of serially diluted pooled cDNA, the
amplification efficiency of the target (cytokines) compared to
reference (GAPDH) genes was examined using SYBR Green
detection. Using the equation pointed out in methods, efficiency of
GAPDH was 96% while that of targets were between 91% and
95%.
Intracellular cytokine staining (ICS)
Seventy two hrs after SLA stimulation of CD4
+/CD8
+ T cells,
part of the cells were harvested and stimulated with PMA plus
Ionomycin for 5–6 hrs, stained for intracellular IFN-c with
conjugated mAbs and the frequency of positive cells was analyzed
using flow cytometry. In CD8
+ cells compartment, antibody to
CD56 marker allowed to exclude IFN-c positive populations of
natural killer cell sources (Fig. 4 A and B). Results of analysis of
cells from HCL volunteers and healthy controls were pooled
separately and presented as median number of intracellular IFN-c
positive CD4
+ and CD8
+ T cells (Fig. 4C). Based on this analysis,
HCL volunteers showed that a significantly higher number of
Table 2. Basic information of the volunteers.
Characteristic HCL Control
Sex: M/F 9/5 12/6
Age 29610.5 34.966.7
Number of lesion 1 (1–10) NA
Duration of the lesion(s) (Months) 3 (1.5–5) NA
Time between healing and sampling
(Months)
1 (1–120) NA
Leishmanin Skin Test (mm) 10.767.48 0
Age and LST: Mean6S.D.
Others: Median (Range).
NA=not applicable.
doi:10.1371/journal.pntd.0000845.t002
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+ T cells were positive for intracellular IFN-c production than
CD8
+ cells (P=0.014).
Discussion
Resistance and susceptibility to L. major infection in murine
model depend upon induction of Th1 or Th2 response,
respectively [8,9,39]. Recovery from CL usually is accompanied
with long lasting protection and strong immune response
generation indicated by in vivo LST and in vitro lymphocyte
response to Leishmania antigens [10,12,13,19,40], yet in human
leishmaniasis the surrogate marker(s) of protection is not well
defined. Most of the studies performed on human immune
response against leishmaniasis is carried out on crude PBMCs
without purifying CD4
+ T cell and CD8
+ population and there is
no report to show a clear-cut CD4
+ Th1/Th2 response [34]. In
the current study cytokines patterns of CD4
+ Th1/Th2 and CD8
+
T cells in volunteers recovered from CL is evaluated at the
transcript and protein levels.
The results of soluble Leishmania antigens (SLA) stimulated cells
showed that pure CD4
+ T cells induced a significantly higher IFN-
c production in HCL volunteers compared to that of healthy
controls, IL-5 as a Th2 type cytokine was not detectable and IL-10
and IL-13 levels were not significantly different in culture of T cells
from HCL volunteers compared with that of healthy controls. At
the same time, the level of cytokines’ mRNA expression was
Figure 2. Cytokine profile of CD4
+ and CD8
+ T cells after SLA
stimulation. Purified CD4
+ and CD8
+ T cells were adjusted to 1–2610
5
cells/well in a U-bottomed 96-well plates and co-cultured with 1:10 of
mitomycin treated autologous monocytes in cRPMI 1640 supplemented
with 10% human AB Rh+ serum. IFN-c, IL-5, IL-10, and IL-13 were
titrated on supernatant of SLA stimulated of CD4
+ (A) and CD8
+ (B) T
cells at 72 hrs of culture using sandwich ELISA method. The amount of
IL-5 was not detectable in the culture supernatants. Filled symbols
represent HCL volunteers; Open symbols represent healthy controls.
doi:10.1371/journal.pntd.0000845.g002
Figure 3. Relative expression of cytokine genes in SLA
stimulated CD4
+ and CD8
+ T cells to unstimulated cells (blank
wells) of culture. Total RNA was extracted from stimulated CD4
+ and
CD8
+ T cells of culture and reverse transcription of mRNA to cDNA was
performed using M-MuLV enzyme. Two steps Real-time PCR was set on
cDNA samples using SYBR Green I system and specific primer pairs.
Threshold cycles (Cts) of each amplicon was used for further analysis.
The relative quantities of the target genes were normalized against the
relative quantities of the internal standard (GAPDH). Fold-expression
changes were calculated using the equation 2
2DDCT. A) relative
expression of cytokine genes in CD4
+ T cells B) relative expression of
cytokine genes in CD8
+ T cells.
doi:10.1371/journal.pntd.0000845.g003
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stimulation at transcript level, after several experiments to explore
the optimum stimulation time points for mRNA analysis.
Simultaneous analysis of cytokines gene expression showed a
strong up-regulation of Th1 cytokine IFN-c mRNA in CD4
+ T
cells. In line with the results of secreted proteins, level of Th2
cytokines transcripts including IL-5, IL-10 and IL-13 showed no
significant increase in HCL volunteers compared with healthy
control. The up-regulation of IFN-c transcripts expression in
Leishmania stimulated CD4
+ T cells consistent with IFN-c secretion
is an indication of Th1 type of response in HCL volunteers parallel
with no Th2 response indicating by low level of IL-5, IL-10 and
IL-13 cytokines.
Analysis of cytokine secretion and transcript expression of SLA
stimulated CD8
+ T cells showed also a significantly higher IFN-c
production in HCL volunteers compared to the healthy control
volunteers. Similar to CD4
+ T cells, the levels of IL-10 and IL-13
were not significantly different in CD8
+ T cell culture between
HCL volunteers and healthy controls. When CD4
+ and CD8
+ T
cell response was compared, the level of IFN-c secretion in SLA
stimulated cells was not significantly different between CD4
+ and
CD8
+ cells, but real-time PCR analysis revealed that expression
Figure 4. Frequency of purified CD4
+/CD8
+ T cells producing intracellular IFN-c. A portion of the cells at 72 hrs of SLA stimulation was used
for ICS assay. Cells were adjusted at about 5610
5/ml and stimulated with PMA + Ionomycin for 5–6 hrs. Monensin was added during the last 4–5 hrs
of culture. Cells were permeabilized and stained for intracellular IFN-c with conjugated mAbs. A) One representative flow cytometry plot showing
intracellular IFN-c positive fractions of gated populations of CD4
+ and CD8
+ T cells in HCL volunteers. B) One representative flow cytometry plot
showing intracellular IFN-c positive fractions of gated populations of CD4
+ and CD8
+ T cells in healthy controls. C) Flow cytometry data of all
volunteers were pooled and are shown as Median (horizontal line) with interquartile ranges (box) and range (whiskers) of intracellular IFN-c positive
cells.
doi:10.1371/journal.pntd.0000845.g004
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+ T cells than CD8
+ T
cells. To confirm the real-time PCR results, part of CD4
+/CD8
+
sorted T cells were harvested following SLA stimulation and
intracellular production of IFN-c was assessed using flow
cytometry. Results of intracellular cytokine staining (ICS) in
HCL volunteers confirmed that a significantly higher number of
CD4
+ T cells produced intracellular IFN-c compared with CD8
+
T cells (median=15% vs. 8%). Based on the results it seems that
the source of IFN-c production is both CD4+ Th1 cells and CD8+
cells in individuals with history of CL.
The role of CD8
+ T cells in human Leishmania infection is not
well known and existed reports are controversial. In a study
performed on Sudanese individuals it was suggested that IFN-c
production is associated with CD4
+ T cells rather than CD8
+ T
cells in individuals with history of CL due to L. major [40]. A report
from New World leishmaniasis showed that in both asymptomatic
and antimonial treated CL individuals caused by L. braziliensis,a
higher proportions of CD4
+ than CD8
+ T cells was present [34].
In another report the authors showed that after treatment of CL
due to L. braziliensis, the frequency of CD4
+ and CD8
+ T cells was
the same with approximately constant production of IFN-c [41].
On the other hand, some clinical studies reported high numbers of
Leishmania specific CD8
+ T cells in the lesions and peripheral blood
during acute phase and healing process in L. major or L. braziliensis
CL patients [42,43]. In mice, the requirement of CD8
+ T cells for
the control of L. major infection is shown to be partly dependent on
the procedure of challenge: b2-microglobuine or CD8
+ deficient
C57BL/6 mice when challenged with high dose of L. major have
the ability to cure the lesion, which indicates that CD8
+ T cells are
not necessary for the control of primary [44] infection, while in the
intradermal challenge with low dose (100 metacyclic promastigotes
into the ear dermis) the outcome of primary L. major infection in
anti-CD8 Ab treated or CD8 deficient mice was dependent on the
CD8
+ T cells [45]. The role of CD8
+ T cells was studied in CBA
and anti-CD4 mAb treated BALB/c mice healed from L. major
infection. The cured mice were re-challenged with L. major in the
contralateral footpad and lymph nodes cells were depleted of
CD4
+ T cells and stimulated in vitro. The remaining CD8
+ T cells
produced a significant amount of IFN-c [31]. It is believed that in
the resolution of the primary Leishmania infection and induction of
protection in murine model CD8
+ T cells play an important role
[31].
In the present study, following the isolation of CD4+/CD8+ T
cells, Th1/Th2 cytokines were titrated on culture supernatant of in
vitro restimulated T cells to check the type of immune response
elicited against Leishmania antigen. The main cytokine produced
was found to be IFN-c in the volunteers’ T cells. IFN-c eliminates
intracellular pathogens primarily through macrophage activation.
Macrophages upon activation produce nitric oxide (NO) which
inhibits growth of intracellular pathogens. It is shown that during
active lesion of CL due to L. major the proliferative response and
IFN-c production of PBMC was increased [12,46] and T cells
from healed CL produced a significantly higher level of IFN-c but
a low level of IL-10 than the cells from controls [14,15,40].
Similarly, studies in L. braziliensis infection demonstrated a Th1/
Th2 mixed response in early stage of active CL [11,42] and then a
sustained Th1 response with elevated level of IFN-c and down-
regulation of IL-4 and IL-10 production were seen apparently
associated with healing [11]. Likewise, the presence of high level of
IFN-c in the skin lesions of CL patients support the role of IFN-c
in healing process [46]. Using RT-PCR, the cytokine patterns of
skin lesions of CL patients showed predominance IFN-c, and low
levels of IL-5 and IL-10 [17]. The contribution of IFN-c to the
recall of immunological memory against L. major reinfection was
assessed in mice. The neutralization of IFN-c at the time of
reinfection reduced the specific DTH response, showing the
involvement of IFN-c in the recall of memory response to L. major
[31]. Similarly in intracellular infection with T. gondii, it is shown
that CD8
+ T cells confers resistance against acute infection [20]
and IFN-c producing CD8
+ T cells play a significant role in
controlling chronic T. gondii infection and inhibits encephalitis in
mouse model [21,22].
In the current study, even though using real-time PCR the
expression level of IFN-c transcripts in CD8
+ cells was less than
CD4
+ cells, but interestingly a significant amount of IFN-c was
produced by CD8
+ T cells in cell culture and around 5–12% of
CD8
+ cells was positive for IFN-c secretion by ICS assay. It is
concluded that CD8
+ T cells contribute along with CD4
+ Th1
cells in IFN-c production in individuals with history of CL. Despite
the limited reports of CD4
+ Th1 cells as the main source of IFN-c
production in CL patients [47,48] in most studies of CD4
+ Th1/
Th2 paradigm in human CL, PBMCs rather than purified T cells
were used, hence the role of IFN-c producing CD8
+ T cells should
not be ruled out when reporting a ‘‘Th1’’ type response in PBMC
culture.
The strong lymphoproliferative and IFN-c response in self
healing CL caused by L. braziliensis is previously shown [49,50]. In
the current study, HCL volunteers with spontaneous healing
during 1.5–5 months were recruited. Individuals with history of
self healing CL are presumed to be protected against further
Leishmania infection. The blood samples were collected a few
months to years after cure of CL lesions. The strong LST response
(mean LST=10.767.5 mm) and IFN-c production is an indica-
tion of sustaining cell mediated immune response. This sustaining
protective immunity is mediated not only through the expansion of
antigen-specific IFN-c producing CD4
+ Th1 cells, but also
through IFN-c producing CD8
+ T cells. The question that which
one of these T cell subsets plays a more important role in IFN-c
production at the initiation of exposure to sand fly bite needs to be
explored.
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